Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MEDIW LTDNARY SHARES
No Price
28.04.2026 20:00
Current Prices from MEDIW LTDNARY SHARES
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ
MDWD
USD
28.04.2026 20:00
16,56 USD
-0,01 USD
-0,06 %
IEX
MDWD
USD
28.04.2026 19:59
16,55 USD
-0,02 USD
-0,12 %
Company Profile for MEDIW LTDNARY SHARES Share
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
